Overview

A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants

Status:
Completed

Trial end date:
2021-11-23

Target enrollment:

Participant gender:

Summary

This study will evaluate the effect of multiple oral doses of itraconazole, on the pharmacokinetics of etrumadenant when etrumadenant is administered as a single dose in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Arcus Biosciences, Inc.

Treatments:

Itraconazole